ARTICLE | Clinical News
Human embryonic germ cells regulatory update
December 24, 2001 8:00 AM UTC
Johns Hopkins University (Baltimore, Md.) received U.S. Patent No. 6,331,406 covering the use of human embryonic germ cells in drug screening assays. GERN is the exclusive licensee of the patent. ...